How will the entry of biosimilars alter competitive pricing strategies?
The expiration of patents for first-generation TNF-alpha inhibitors has paved the way for biosimilars. This influx of lower-cost alternatives is forcing originators to either innovate rapidly with next-generation biologics or engage in aggressive price-matching to maintain their market share.
Why does HS Biosimilar Market Penetration matter for 2024?
In 2024, we are seeing a significant shift in European markets toward mandatory biosimilar switching. Understanding HS Biosimilar Market Penetration is vital for manufacturers planning their lifecycle management strategies. By 2025, biosimilars are expected to capture 30-40% of the volume in the "bio-naive" patient segment.
Lifecycle management: The move to high-concentration formulations
To differentiate from biosimilars, original manufacturers are launching "citrate-free" and high-concentration formulations. these enhancements reduce injection site pain and improve the patient experience, maintaining brand loyalty even in a price-sensitive environment.
|
Market Segment
|
2024 Competitive Driver
|
2025 Predicted Trend
|
|
Originator Biologics
|
Brand Trust/Patient Support
|
Next-Gen Mechanism Launches
|
|
Biosimilars
|
Lower ASP (Average Sales Price)
|
Market share dominance in EU
|
|
Next-Gen Biologics
|
Superior Efficacy (IL-17/23)
|
Dominance in "Bio-Experienced" patients
|
Market Outlook for 2025
The year 2025 will be characterized by a "two-tier" market. Low-cost biosimilars will be used for stable, moderate patients, while premium, next-generation biologics will be reserved for severe or refractory cases, ensuring sustainable growth across both segments.
Author: Sofiya Sanjay
Designation: Healthcare Research Consultant, Market Research Future
About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.
Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com
Italiano
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek